Skip to main content
رجوع
OPK logo

OPKO Health, Inc.

جودة البيانات: 100%
OPK
NASDAQ Healthcare Medical - Diagnostics & Research
KWD 1.19
▲ KWD 0.06 (5.31%)
القيمة السوقية: 913.56M
نطاق اليوم
KWD 1.14 KWD 1.20
نطاق 52 أسبوعًا
KWD 1.10 KWD 1.83
حجم التداول
3,425,401
متوسط 50 يوم / 200 يوم
KWD 1.24 / KWD 1.34
الإغلاق السابق
KWD 1.13

Quick Summary

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (631 نظير)

المقياس السهم وسيط القطاع
P/E -4.1 0.2
P/B 0.7 3.0
ROE % -17.1 3.6
Net Margin % -37.2 3.8
Rev Growth 5Y % -23.5 9.9
D/E 0.3 0.2

السعر المستهدف للمحللين

Hold
KWD 1.60 +34.5%
ربحية السهم المستقبلية
-KWD 0.28
الإيرادات المقدّرة
551.21M

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2030 -KWD 0.04
-KWD 0.04 – -KWD 0.04
688.35M 1
FY2029 -KWD 0.08
-KWD 0.08 – -KWD 0.08
648.25M 1
FY2028 -KWD 0.08
-KWD 0.16 – KWD 0.00
608.10M 3

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-02-26 -KWD 0.07 -KWD 0.04 +41.7%
2025-10-29 -KWD 0.02 KWD 0.03 +250.0%
2025-07-31 -KWD 0.12 -KWD 0.19 -58.3%
2025-04-30 -KWD 0.06 -KWD 0.10 -66.7%
2025-02-27 -KWD 0.08 KWD 0.01 +112.5%
2024-11-07 -KWD 0.10 KWD 0.03 +130.0%
2024-08-07 -KWD 0.09 -KWD 0.01 +88.9%
2024-05-07 -KWD 0.09 -KWD 0.12 -33.3%

Dividend History

Yield

0.00%

Payout Ratio

0.00%

Growth (3Y)

N/A

Growth (5Y)

N/A

No dividend history available.

النقاط الرئيسية

Revenue declined -23.53% annually over 5 years
Debt/Equity of 0.34 — conservative balance sheet
Negative free cash flow of -190.82M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 8.63%
Capital efficient — spends only 2.02% of revenue on capex

النمو

Revenue Growth (5Y)
-23.53%
Revenue (1Y)-14.90%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-17.14%
ROIC-9.65%
Net Margin-37.20%
Op. Margin-36.08%

الأمان

Debt / Equity
0.34
Current Ratio3.97
Interest Coverage-2.16

التقييم

P/E Ratio
-4.05
Forward P/EN/A
P/B Ratio0.72
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) -14.90% Revenue Growth (3Y) -16.17%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -23.53% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 606.88M Net Income (TTM) -225.73M
ROE -17.14% ROA -11.68%
Gross Margin 21.10% Operating Margin -36.08%
Net Margin -37.20% Free Cash Flow (TTM) -190.82M
ROIC -9.65% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.34 Current Ratio 3.97
Interest Coverage -2.16
Dividends
Dividend Yield 0.00% Payout Ratio 0.00%
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -4.05 Forward P/E N/A
P/B Ratio 0.72 P/S Ratio 1.51
PEG Ratio -0.02 Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S 1.66 Fwd Earnings Yield N/A
FCF Yield -20.89%
Market Cap 913.56M Enterprise Value 978.09M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 606.88M 713.14M 863.50M 1.00B 1.77B
Net Income -225.73M -53.22M -188.86M -328.41M -30.14M
EPS (Diluted) -0.30 -0.08 -0.25 -0.46 -0.05
Gross Profit 128.05M 311.03M 318.13M 288.22M 581.52M
Operating Income -218.99M -152.07M -157.02M -226.25M 18.75M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 1.93B 2.20B 2.01B 2.17B 2.40B
Total Liabilities 663.99M 834.76M 622.48M 605.61M 714.59M
Shareholders' Equity 1.27B 1.37B 1.39B 1.56B 1.69B
Total Debt 433.60M 504.44M 326.56M 305.55M 254.76M
Cash & Equivalents 369.07M 431.94M 95.88M 153.19M 134.71M
Current Assets 581.88M 662.09M 309.48M 394.53M 823.01M
Current Liabilities 146.68M 193.10M 200.05M 213.48M 330.01M